- Lexaria
Bioscience is an innovator in the field of bioavailable lipophilic active
compounds, and it is working to make consumption of certain products
through oral ingestion a viable alternative to inhalation
- A
particular focus of the company’s technology is to ensure that
cannabinoids can enter the blood stream at speeds comparable to smoking
and can be used in a discrete manner
- Cannabis-infused
beverage sales are expected to surpass $1.4 billion by 2024, marking a
nearly 15-fold increase over 2018 levels
Drug bio-delivery technology innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has
launched online commercial delivery of the cannabis industry’s most advanced
water-soluble multi-spectrum hemp oil in a powdered format, making high-quality
hemp oil with cannabidiol (CBD) readily available to meet the beverage infusion
needs of consumers in the United States.
The company’s August 22 announcement (http://ibn.fm/Ljt7D) states that
its ChrgD+ product is powered by Lexaria’s proprietary DehydraTECH(TM)
technology for rapid CBD delivery to the user’s bloodstream within 15 minutes –
sometimes as fast as two minutes in lab testing.
The rapid bio-delivery of CBD through DehydraTECH provides
an avenue for safer, less conspicuous consumption of CBD than inhaling it
through smoke or vapor during a critical time when social acceptance of
cannabis products is exploding age-old prohibitions but many legislative
entities continue to struggle with regulatory issues on behalf of the public
welfare.
ChrgD+ has been available in a limited number of retail
stores throughout the western United States, but the announcement that it is
now available via commercial web delivery to locations where it can be legally
consumed means that anyone has the potential to obtain it through the
website www.ChrgD.life without
having to travel. Limited-time promotional offers and product updates are also
available through the site.
Each serving of ChrgD+ weighs just two grams, making it easy
for a consumer to carry multiple servings in a shirt pocket or athletic wear
while on the go. The multi-spectrum oil-based powder can be poured innocuously
into any hot or cold beverage, and every package contains a manufacturing batch
code that makes it simple for consumers to browse lab test results for the
actual potency of the package’s ingredients (which contain no THC) as part of
Lexaria’s push for transparency.
DehydraTECH technology provides the added benefit of gently
removing unpleasant cannabis flavors, so ChrgD+ is able to avoid the artificial
flavors or sweeteners that other products may use to mask the strong flavors
and aromas inherent to hemp oil.
These innovations are examples of Lexaria’s ongoing mission
to enhance the “speed of action, flavor and gastro-intestinal delivery of
orally-administered products,” particularly those that utilize cannabinoids,
nicotine and ibuprofen.
Zenith Global’s industry analysts predict that the U.S.
market for cannabis- and hemp-infused drinks will reach more than $1.4 billion
by 2024, almost 15-times the 2018 level, as part of an overall trend toward
life-enhancing practices that focus on alternatives to traditional medicines
and recreational products, including alcoholic beverages and tobacco
products (http://ibn.fm/V6ucn).
With the federal legalization of edible cannabis products
only a month away in Canada, Lexaria is also preparing to roll out
DehydraTECH-licensed products in collaboration with alcohol-free beer, wine and
adult format beverage maker Hill Street Beverage Company Inc. (TSX.V: BEER) on
a first-time business-to-business (B2B) basis between Canada’s licensed
producers and other businesses licensed by Health Canada to make
cannabis-infused edibles. The as-yet unnamed new brand will feature processed
tetrahydrocannabinol (THC) and/or CBD powder from cannabis or its less
chemically psychoactive hemp variant as part of the companies’ efforts to build
production in a new market space.
For more information, visit the company’s website at www.LexariaBioscience.com
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
